- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x QCG: (2S)-tert-butoxy[7-(8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl)-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid(Non-covalent)
QCG.5: 18 residues within 4Å:- Chain A: Q.122, A.123, E.124, H.125, K.127, T.128, M.132
- Chain B: Q.49, A.52, Y.53, L.56, T.78, T.79, A.82, A.83, W.86
- Ligands: 1PE.1, 1PE.2
9 PLIP interactions:5 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:Q.49, B:Y.53, B:T.79, B:A.82, B:W.86
- Hydrogen bonds: A:E.124, A:H.125, A:H.125
- Salt bridges: A:H.125
QCG.11: 18 residues within 4Å:- Chain A: Q.49, A.52, Y.53, L.56, T.78, T.79, A.82, A.83, W.86
- Chain B: Q.122, A.123, E.124, H.125, K.127, T.128, M.132
- Ligands: 1PE.9, 1PE.10
9 PLIP interactions:4 interactions with chain A, 5 interactions with chain B- Hydrophobic interactions: A:Q.49, A:A.82, A:W.86, B:T.128
- Water bridges: A:Q.49
- Hydrogen bonds: B:E.124, B:H.125, B:H.125
- Salt bridges: B:H.125
- 6 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 5 residues within 4Å:- Chain A: K.25, R.120, E.124, H.125, L.126
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.120, A:L.126
- Water bridges: A:K.127
- Salt bridges: A:K.25, A:H.125
SO4.7: 3 residues within 4Å:- Chain A: T.20, H.21, K.113
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:T.20, A:T.20, A:H.21, A:N.109
- Salt bridges: A:H.21, A:K.113
SO4.8: 5 residues within 4Å:- Chain A: T.47, G.48, Q.49, S.77, T.79
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:G.48, A:Q.49, A:S.77, A:T.79, A:T.79
- Water bridges: A:Q.49
SO4.12: 5 residues within 4Å:- Chain B: T.47, G.48, Q.49, S.77, T.79
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:G.48, B:Q.49, B:Q.49, B:S.77, B:T.79, B:T.79
- Water bridges: B:T.47, B:T.79
SO4.13: 3 residues within 4Å:- Chain B: D.70, N.71, G.94
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.71, B:N.71
SO4.14: 5 residues within 4Å:- Chain B: K.25, R.120, E.124, H.125, L.126
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:R.120, B:L.126
- Water bridges: B:K.127, B:K.127
- Salt bridges: B:K.25, B:H.125
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, G. et al., Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-03-04
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.33 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 2 x QCG: (2S)-tert-butoxy[7-(8-fluoro-5-methyl-3,4-dihydro-2H-1-benzopyran-6-yl)-5-methyl-2-phenylpyrazolo[1,5-a]pyrimidin-6-yl]acetic acid(Non-covalent)
- 6 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Li, G. et al., Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-03-04
- Peptides
- Integrase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B